These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22281155)

  • 21. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma.
    Samuel M; Chow PK; Chan Shih-Yen E; Machin D; Soo KC
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD001199. PubMed ID: 19160192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study.
    Chau GY; Lui WY; Tsay SH; Chao Y; King KL; Wu CW
    Ann Surg Oncol; 2006 Oct; 13(10):1329-37. PubMed ID: 16897271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: a meta-analysis.
    Zheng Z; Liang W; Wang D; Schroder PM; Ju W; Wu L; Zheng Z; Shang Y; Guo Z; He X
    Int J Cancer; 2015 Mar; 136(6):E751-9. PubMed ID: 25208979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach.
    Shen YC; Hsu C; Chen LT; Cheng CC; Hu FC; Cheng AL
    J Hepatol; 2010 Jun; 52(6):889-94. PubMed ID: 20395009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin analogues in chemoprevention of hepatocellular carcinoma after resection or ablation--a systematic review and meta-analysis.
    Chu KJ; Lai EC; Yao XP; Zhang HW; Lau WY; Fu XH; Lu CD; Shi J; Cheng SQ
    Asian J Surg; 2010 Jul; 33(3):120-6. PubMed ID: 21163409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic resection combined with radiofrequency ablation versus hepatic resection alone for multifocal hepatocellular carcinomas: A meta-analysis.
    Xu LL; Zhang M; Yi PS; Zheng XB; Feng L; Lan C; Tang JW; Ren SS; Xu MQ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):974-980. PubMed ID: 29270762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review and meta-analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma.
    Huang TS; Shyu YC; Chen HY; Yuan SS; Shih JN; Chen PJ
    J Viral Hepat; 2013 Oct; 20(10):729-43. PubMed ID: 24010648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
    Lau WY; Lai EC; Leung TW; Yu SC
    Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.
    Bruix J; Takayama T; Mazzaferro V; Chau GY; Yang J; Kudo M; Cai J; Poon RT; Han KH; Tak WY; Lee HC; Song T; Roayaie S; Bolondi L; Lee KS; Makuuchi M; Souza F; Berre MA; Meinhardt G; Llovet JM;
    Lancet Oncol; 2015 Oct; 16(13):1344-54. PubMed ID: 26361969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: a meta-analysis of randomized controlled trials.
    Zhang CH; Xu GL; Jia WD; Li JS; Ma JL; Ge YS
    Int J Cancer; 2011 Sep; 129(5):1254-64. PubMed ID: 21710498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
    Schoppmeyer K; Weis S; Mössner J; Fleig WE
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006745. PubMed ID: 19588401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The current role of neoadjuvant/adjuvant/chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma: a systematic review.
    Lau WY; Lai EC; Lau SH
    Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):124-33. PubMed ID: 19357024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage.
    Liu CJ; Lee PH; Lin DY; Wu CC; Jeng LB; Lin PW; Mok KT; Lee WC; Yeh HZ; Ho MC; Yang SS; Lee CC; Yu MC; Hu RH; Peng CY; Lai KL; Chang SS; Chen PJ
    J Hepatol; 2009 May; 50(5):958-68. PubMed ID: 19303160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative adjuvant arterial infusion chemotherapy for patients with hepatocellular carcinoma.
    Nakashima K; Kitano S; Kim YI; Aramaki M; Kawano K
    Hepatogastroenterology; 1996; 43(12):1410-4. PubMed ID: 8975940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
    Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
    Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
    Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
    Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An updated meta-analysis of randomized controlled trials assessing the effect of sorafenib in advanced hepatocellular carcinoma.
    Peng S; Zhao Y; Xu F; Jia C; Xu Y; Dai C
    PLoS One; 2014; 9(12):e112530. PubMed ID: 25460347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis.
    Zhang G; Yu X; Liu P; Huang X; Jiang X
    Dig Dis Sci; 2018 Dec; 63(12):3207-3219. PubMed ID: 30140982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A meta-analysis of adoptive immunotherapy in postoperative hepatocellular carcinoma.
    Zhao H; Zheng M; Wang K; Wang L; He H; Wang M; Shi Y; Huang S; Ji F; Li X; Zhu H; Wang L; Zhang X; Shi X; Zhao S; Fu B; Wu T
    J Cancer Res Ther; 2018; 14(4):807-814. PubMed ID: 29970657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.